Source: Eur Respir J 2010; 36: 615-621
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Kolditz M., Halank M., Schulte-Hubbert B., Höffken G.. Adrenal function is related to prognosis in moderate community-acquired pneumonia. Eur Respir J 2010; 36: 615-621

Member's Comments

No comment yet.

Related content which might interest you: Thrombocytosis is a marker of poor outcome in community-acquired pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Thyroid hormones implication in severe community-acquired pneumonia (SCAP): Relationship with survival, outcomes and clinical complications Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 is hypercapnia associated with severe forms of community-acquired pneumonia? Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Obesity is associated with improved outcome in community-acquired pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Detection of liver function in patients with severe community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer Source: Eur Respir Rev 2008; 17: 83-85 Year: 2008 Adrenal function in patients with community-acquired pneumonia Source: Eur Respir J 2008; 31: 1268-1273 Year: 2008 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020 Prediction of prognosis in healthcare-associated pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008